Nitazoxanide

硝唑尼特

Report date: 2026/04/18 20:00:19
NMEFirst In Class

Base Information

Drug NameNitazoxanide
Drug Alias Name硝唑沙奈nitazoxanidanitazoxanidumColufaseCryptaz +[11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate synthase inhibitors
TargetsPyruvate synthase
Therapy Area/IndicationsRhinovirus infectionCoronavirus Disease 2019 (COVID-19)Norovirus Infections +[25
Global Approved IndicationsGiardiasisCryptosporidiosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2002/11/22
Country/TerritoryUnited StatesSingaporeThailand +[13
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesRomark Laboratories
China Registration ClassN/A

Develop Information

Active IndicationsCoronavirus Disease 2019 (COVID-19)Norovirus InfectionsDiarrhea +[9
Inactive IndicationsRhinovirus infectionRespiratory Tract DiseasesCrohn Disease +[16

Other Information

ATC CodeP01AX11